Hanmi Pharm. Co., Ltd. (KRX:128940)

Hanmi Pharm. Revenue

Hanmi Pharm. had revenue of 467.25B KRW in the quarter ending June 30, 2026, with 29.33% growth. This brings the company's total for the last twelve months to 1.66T, up 12.93% year-over-year. In the year 2025, Hanmi Pharm. had annual revenue of 1.55T with 3.48% growth. That makes Hanmi Pharm. the 6,739th largest company in the world by revenue and 297th in South Korea.

• Revenue (ttm): 1.66T
• Revenue Growth: +12.93%
• P/S Ratio: 3.18
• Revenue / Employee: 708.07M
• Employees: 2,338
• Market Cap: 5.27T

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Medicine 1.15T 69.9%
• Overseas Pharmaceuticals 402.40B 24.5%
• Active Pharmaceutical Ingredients 91.28B 5.6%

By Geography

Chart

• Republic of Korea 947.03B 61.2%
• China 405.75B 26.2%
• Other 90.34B 5.8%
• The United States of America 82.24B 5.3%
• Japan 22.17B 1.4%

Fiscal year ended Dec 31, 2025 See the full Hanmi Pharm. breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.55T	52.03B	3.48%
Dec 31, 2024	1.50T	4.61B	0.31%
Dec 31, 2023	1.49T	159.34B	11.97%
Dec 31, 2022	1.33T	128.36B	10.67%
Dec 31, 2021	1.20T	127.33B	11.84%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 30, 2026

Data Sources Report a data error